Literature DB >> 32788216

A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.

Carola Munoz-Montesino1, Djabir Larkem1, Clément Barbereau1, Angélique Igel-Egalon1, Sandrine Truchet1, Eric Jacquet2, Naïma Nhiri2, Mohammed Moudjou1, Christina Sizun2, Human Rezaei1, Vincent Béringue1, Michel Dron3.   

Abstract

Prions result from a drastic conformational change of the host-encoded cellular prion protein (PrP), leading to the formation of β-sheet-rich, insoluble, and protease-resistant self-replicating assemblies (PrPSc). The cellular and molecular mechanisms involved in spontaneous prion formation in sporadic and inherited human prion diseases or equivalent animal diseases are poorly understood, in part because cell models of spontaneously forming prions are currently lacking. Here, extending studies on the role of the H2 α-helix C terminus of PrP, we found that deletion of the highly conserved 190HTVTTTT196 segment of ovine PrP led to spontaneous prion formation in the RK13 rabbit kidney cell model. On long-term passage, the mutant cells stably produced proteinase K (PK)-resistant, insoluble, and aggregated assemblies that were infectious for naïve cells expressing either the mutant protein or other PrPs with slightly different deletions in the same area. The electrophoretic pattern of the PK-resistant core of the spontaneous prion (ΔSpont) contained mainly C-terminal polypeptides akin to C1, the cell-surface anchored C-terminal moiety of PrP generated by natural cellular processing. RK13 cells expressing solely the Δ190-196 C1 PrP construct, in the absence of the full-length protein, were susceptible to ΔSpont prions. ΔSpont infection induced the conversion of the mutated C1 into a PK-resistant and infectious form perpetuating the biochemical characteristics of ΔSpont prion. In conclusion, this work provides a unique cell-derived system generating spontaneous prions and provides evidence that the 113 C-terminal residues of PrP are sufficient for a self-propagating prion entity.
© 2020 Munoz-Montesino et al.

Entities:  

Keywords:  cell culture; infection; mutant; prion; prion diseases; protein aggregation; protein stability; proteinase; recombinant protein expression; structural biology

Year:  2020        PMID: 32788216      PMCID: PMC7549040          DOI: 10.1074/jbc.RA120.014738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.

Authors:  Cécile Féraudet; Nathalie Morel; Stéphanie Simon; Hervé Volland; Yveline Frobert; Christophe Créminon; Didier Vilette; Sylvain Lehmann; Jacques Grassi
Journal:  J Biol Chem       Date:  2004-12-23       Impact factor: 5.157

2.  alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts.

Authors:  Adrian R Walmsley; Nicole T Watt; David R Taylor; W Sumudhu S Perera; Nigel M Hooper
Journal:  Mol Cell Neurosci       Date:  2008-11-12       Impact factor: 4.314

3.  A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Angelique Igel-Egalon; Clément Barbereau; Jérôme Chapuis; Danica Ciric; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  Prion       Date:  2017-02-08       Impact factor: 3.931

4.  Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  J Mol Biol       Date:  2010-10-07       Impact factor: 5.469

5.  Prion propagation in cells expressing PrP glycosylation mutants.

Authors:  Muhammad K Salamat; Michel Dron; Jérôme Chapuis; Christelle Langevin; Hubert Laude
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

6.  Separate mechanisms act concurrently to shed and release the prion protein from the cell.

Authors:  Lotta Wik; Mikael Klingeborn; Hanna Willander; Tommy Linne
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

7.  Distinct prion proteins in short and long scrapie incubation period mice.

Authors:  D Westaway; P A Goodman; C A Mirenda; M P McKinley; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

Review 8.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

9.  Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice.

Authors:  Walker S Jackson; Andrew W Borkowski; Henryk Faas; Andrew D Steele; Oliver D King; Nicki Watson; Alan Jasanoff; Susan Lindquist
Journal:  Neuron       Date:  2009-08-27       Impact factor: 17.173

10.  A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.

Authors:  Robert C C Mercer; Nathalie Daude; Lyudmyla Dorosh; Ze-Lin Fu; Charles E Mays; Hristina Gapeshina; Serene L Wohlgemuth; Claudia Y Acevedo-Morantes; Jing Yang; Neil R Cashman; Michael B Coulthart; Dawn M Pearson; Jeffrey T Joseph; Holger Wille; Jiri G Safar; Gerard H Jansen; Maria Stepanova; Brian D Sykes; David Westaway
Journal:  PLoS Pathog       Date:  2018-01-16       Impact factor: 6.823

View more
  2 in total

Review 1.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

2.  Caprine PRNP polymorphisms N146S and Q222K are associated with proteolytic cleavage of PrPC.

Authors:  Sally A Madsen-Bouterse; Paula Stewart; Helen Williamson; David A Schneider; Wilfred Goldmann
Journal:  Genet Sel Evol       Date:  2021-06-19       Impact factor: 4.297

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.